<DOC>
	<DOC>NCT01823887</DOC>
	<brief_summary>The ANTHEM-HF Study is designed to demonstrate the safety and efficacy of vagus nerve stimulation (VNS) with the Cyberonics VNS Therapy System for the treatment of subjects with symptomatic heart failure.</brief_summary>
	<brief_title>Autonomic Neural Regulation Therapy to Enhance Myocardial Function in Heart Failure (ANTHEM-HF) Study</brief_title>
	<detailed_description>Heart failure patients will be enrolled and randomized to cervical VNS implantation on either the left side or right side. After a 2-week post-implantation recovery period and a 10-week stimulation titration period, continuous periodic stimulation will be performed for 6 months, with data collection at 3 months and 6 months.</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Patients with symptomatic heart failure, New York Heart Association (NYHA) class II/III with reduced EF and dilated hearts</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Heart Failure</keyword>
	<keyword>Vagus Nerve</keyword>
	<keyword>VNS</keyword>
</DOC>